INS and metabolic syndrome: An increase in adipokines resistin, leptin, PAI-1 and retinol-binding protein 4 in patients with metabolic syndrome and T2D induce insulin resistance in megakaryocytes by interfering with IRS-1 expression, therefore overcoming the inhibitory effects of insulin on platelets [245].